IPSC — Century Therapeutics Inc · rev $109.2M

Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.

Latest reported IPSC revenue for 2025-09-30 was $109.2M. Net income was $9.6M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. IPSC currently screens at market cap $47.8M.

Use this IPSC page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the IPSC quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the IPSC SEC filings page. Lician reads the product cache first so this HTML stays unique to Century Therapeutics Inc even when a live quote feed is slow.

Century Therapeutics Inc latest statements (FY2025)

Latest cached year on this hub. Full IPSC income, balance, and cash tables.

  • Revenue$109.2M
  • Net Income-$9.6M
  • Total Assets$223.7M
  • Total Debt$0
  • Free Cash Flow-$104.7M

IPSC recent filings